South America Embolization Coils Market

The South America embolization coils market is expected to grow from US$ 107.13 million in 2022 to US$ 130.35 million by 2028; it is estimated to grow at a CAGR of 3.3% from 2022 to 2028.

Rise in Patient Preference for Minimally Invasive Procedures

The number of minimally invasive surgeries is rising as patients increasingly prefer such surgeries due to lesser postoperative pain, postoperative complications, shorter hospital stays, fast recovery times, etc. Noninvasive or minimally invasive treatments are being developed as alternatives to surgery for patients with early-stage breast cancer. For instance, Trans Arterial Chemo Embolization, also known as TACE, is a minimally invasive procedure that is typically used to treat hepatocellular carcinoma. TACE is for patients with asymptomatic and unresectable liver cancer. TACE can be used to diminish the size of the tumor and make the patient eligible for liver transplantation. It is considered an evolution from a formerly applied technique called Trans-Catheter Arterial Embolization (TAE). Bleeding is a common issue in cancer patients, related to local tumor invasion, tumor angiogenesis, systemic effects of cancer, or anti-cancer treatments. TACE involves a two-step process—selective arterial occlusion restricts the blood supply to the tumor, which causes ischemic tumor necrosis, and regional chemotherapy is arranged that helps the drug to remain in the area for a prolonged period, which starts causing the therapeutic effects. Prostatic artery embolization (PAE) is also a minimally invasive therapy implemented as an elective outpatient technique for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The number of patients treated with PAE has grown in recent years. Thus, the increasing preference for minimally invasive procedures is fueling the embolization coils market growth. In Addition, the rise in the awareness about minimally invasive procedures and availability of the reimbursement for minimally invasive procedures are likely to foster the demand for a minimally invasive procedure. Thus, owing to these factors, the South America embolization coils market is likely to propel significantly in the forecast period.

South America Embolization Coils Market Overview

The South America embolization coils market is segmented into Brazil, Argentina, and the rest of South America. The region is expected to experience growth opportunities due to rising incidences of stroke in the countries and rise development in the healthcare systems. The market is also expected to grow due to the rising awareness about the tumors and brain aneurysms in the countries of the region. Brazil, the largest country, and economy in South America is a major driving force behind the development of new medical technologies in the region. The development and improvements in the country have led to easy access to education and technology.

South America Embolization Coils Market Revenue and Forecast to 2028 (US$ Million)

South America Embolization Coils Strategic Insights

Strategic insights for the South America Embolization Coils provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

South America Embolization Coils Report Scope

South America Embolization Coils Regional Insights

The geographic scope of the South America Embolization Coils refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

South America Embolization Coils Market Segmentation

The South America embolization coils market is segmented on the basis of type, material, application, end user, and country. Based on type, the South America embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2022.

Based on material, the South America embolization coils market is segmented into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2022.

Based on application, the South America embolization coils market is segmented into neurology, cardiology, urology, oncology, peripheral vascular disease, and others. The neurology segment held the largest market share in 2022.

Based on end user, the South America embolization coils market is segmented into hospital, cardiac center, ambulatory center, and other. The hospital segment held the largest market share in 2022.

Based on country, the South America embolization coils market is segmented into Brazil, Argentina, and Rest of South America. Brazil dominated the market share in 2022.  

Terumo Corporation; Medtronic; Boston Scientific Corporation; Stryker; KANEKA CORPORATION; MicroPort Scientific Corporation; Penumbra, Inc.; Cook Medical LLC; Johnson & Johnson Services, Inc.; and Shape Memory Medical INC. are the leading companies operating in the South America embolization coils market.